Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 14) 10X Genomics Inc (NASDAQ:...
Plusdental expandiert im Rahmen seines Wachstumskurses in den französischen Markt und ist nun in insgesamt sechs europäischen Ländern vertreten. Das B
Sabio Group hat den Spezialisten für Kundenerfahrungslösungen Anana erworben. Die Übernahme unterstützt das Ziel von Sabio, zum führenden Anbieter auf
Team Gleason is collaborating with Boston Children’s Hospital’s ALS Augmentative Communication Program to provide voice banking and message banking.
American International Group Inc. purchased a new position in Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) during the 2nd quarter, HoldingsChannel reports. The firm purchased 16,310 shares of the bi
Everbridge, Inc. (NASDAQ: EVBG), der weltweit führende Anbieter im Bereich Critical Event Management (CEM), teilte heute mit, dass das Programm des vi
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today the publication of a manuscript titled, "Effects of M
Arizona Metals Corp. (TSX.V:AMC, OTCQB:AZMCF) (the “Company” or “Arizona Metals”) is pleased to announce the first drill hole from its recently comple
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced Ralph Kern, MD, MHSc, President and Chief Medical Off
Evogene Ltd. (NASDAQ:EVGN) Q2 2020 Earnings Conference Call August 5, 2020 09:00 ET Company Participants Ofer Haviv - Chief Executive Officer Dorit Kreiner - Chief Financial Officer Gadi Ben Nissim -
By David Bautz, PhD NASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Topline Data from Phase 3 ALS Trial Before End of November 2020 BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) is c
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today financial results for the second quarter and first half ende
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE